Janux Therapeutics (NASDAQ:JANX) Receives “Buy” Rating from HC Wainwright
Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $70.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 133.41% from the stock’s previous close. Other […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $70.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 133.41% from the stock’s previous close. Other […]
